Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Non-Current Assets (2020 - 2025)

Bio Essence has reported Non-Current Assets over the past 6 years, most recently at $97.0 for Q4 2025.

  • For Q4 2025, Non-Current Assets fell 70.78% year-over-year to $97.0; the TTM value through Dec 2025 reached $97.0, down 70.78%, while the annual FY2025 figure was $97.0, 70.78% down from the prior year.
  • Non-Current Assets for Q4 2025 was $97.0 at Bio Essence, down from $156.0 in the prior quarter.
  • Over five years, Non-Current Assets peaked at $1.8 million in Q3 2023 and troughed at $97.0 in Q4 2025.
  • A 5-year average of $865912.8 and a median of $1.3 million in 2023 define the central range for Non-Current Assets.
  • Biggest five-year swings in Non-Current Assets: skyrocketed 30.59% in 2023 and later crashed 99.98% in 2025.
  • Year by year, Non-Current Assets stood at $1.4 million in 2021, then dropped by 6.5% to $1.3 million in 2022, then tumbled by 84.5% to $208241.0 in 2023, then tumbled by 99.84% to $332.0 in 2024, then tumbled by 70.78% to $97.0 in 2025.
  • Business Quant data shows Non-Current Assets for BIOE at $97.0 in Q4 2025, $156.0 in Q3 2025, and $215.0 in Q2 2025.